Semaglutide is currently being investigated in two large phase III clinical trial programs for treating obesity: the STEP program, which aims to obtain regulatory approval for semaglutide as an anti-obesity drug and is evaluating cardiovascular outcomes in 17,500 patients
The more common side effects of Semaglutide treatment include: Abdominal pain Nausea Vomiting Diarrhea Constipation Bloating Headaches Indigestion There are rare side effects that Semaglutide can also cause
Discover Innovative Solutions for Knee Pain At Tulsi Wellness Club, we are excited about the potential of BPC-157 to offer new avenues for managing knee pain and supporting joint health
For patients using diabetes medications, we manage hypoglycemia risks through careful blood sugar monitoring and adjust treatment plans as needed
GLP-1 medications include injectable forms such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), as well as oral semaglutide (Rybelsus)
